丙酯 | 6628-34-8

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 中文名称: 丙酯
• 中文别名: (2-甲基-1H-吲哚-3-基)-氧代乙酸乙酯
• 英文名称: ethyl 2-(2-methyl-1H-indol-3-yl)-2-oxoacetate
• 英文别名: ethyl 2-methylindol-3-ylglyoxylate；(2-methyl-indol-3-yl)-oxo-acetic acid ethyl ester；(2-methyl-indol-3-yl)-glyoxylic acid ethyl ester；(2-Methyl-indol-3-yl)-glyoxylsaeure-aethylester；ethyl (2-methyl-1H-indol-3-yl)(oxo)acetate；2-methylindole-3-ethylglyoxylate
• CAS: 6628-34-8
• 化学式: C₁₃H₁₃NO₃
• mdl: MFCD00022706
• 分子量: 231.251
• InChiKey: RDKVWTARRVILKC-UHFFFAOYSA-N

物化性质

• 熔点：
  129.5 °C
• 沸点：
  410.0±33.0 °C(Predicted)
• 密度：
  1.242±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.5
• 重原子数：
  17
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.23
• 拓扑面积：
  59.2
• 氢给体数：
  1
• 氢受体数：
  3

安全信息

• 海关编码：
  2918300090

SDS

Version 1.1
Regulation (EC) No 1907/2006

---

1 - Product and Company Information

---

Product Name ETHYL 2-METHYL-3-INDOLYLGLYOXY - 1 GM
LATE

---

2 - Hazards Identification

---

SPECIAL INDICATION OF HAZARDS TO HUMANS AND THE ENVIRONMENT
Not hazardous according to Directive 67/548/EEC.

---

3 - Composition/Information on Ingredients

---

Product Name CAS # EC no Annex I
Index Number
ETHYL 2-METHYL-3-INDOLYLGLYOXYLATE 6628-34-8 None None
Formula C13H13NO3
Molecular Weight 231,2500 AMU

---

4 - First Aid Measures

---

AFTER INHALATION
If inhaled, remove to fresh air. If breathing becomes difficult,
call a physician.
AFTER SKIN CONTACT
In case of contact, immediately wash skin with soap and copious
amounts of water.
AFTER EYE CONTACT
In case of contact with eyes, flush with copious amounts of
water for at least 15 minutes. Assure adequate flushing by
separating the eyelids with fingers. Call a physician.
AFTER INGESTION
If swallowed, wash out mouth with water provided person is
conscious. Call a physician.

---

5 - Fire Fighting Measures

---

ALDRICH www.molbase.com
EXTINGUISHING MEDIA
Suitable: Water spray. Carbon dioxide, dry chemical powder, or
appropriate foam.
SPECIAL RISKS
Specific Hazard(s): Emits toxic fumes under fire conditions.
SPECIAL PROTECTIVE EQUIPMENT FOR FIREFIGHTERS
Wear self-contained breathing apparatus and protective clothing
to prevent contact with skin and eyes.

---

6 - Accidental Release Measures

---

PROCEDURE(S) OF PERSONAL PRECAUTION(S)
Exercise appropriate precautions to minimize direct contact with
skin or eyes and prevent inhalation of dust.
METHODS FOR CLEANING UP
Sweep up, place in a bag and hold for waste disposal. Avoid
raising dust. Ventilate area and wash spill site after material
pickup is complete.

---

7 - Handling and Storage

---

HANDLING
Directions for Safe Handling: Avoid inhalation. Avoid contact
with eyes, skin, and clothing. Avoid prolonged or repeated
exposure.
STORAGE
Conditions of Storage: Keep tightly closed.

---

8 - Exposure Controls / Personal Protection

---

ENGINEERING CONTROLS
Safety shower and eye bath. Mechanical exhaust required.
GENERAL HYGIENE MEASURES
Wash thoroughly after handling.
PERSONAL PROTECTIVE EQUIPMENT
Respiratory Protection: Use respirators and components tested and
approved under appropriate government standards such as NIOSH (US)
or CEN (EU). Respiratory protection is not required. Where
protection from nuisance levels of dusts are desired, use type N95
(US) or type P1 (EN 143) dust masks.
Hand Protection: Protective gloves.
Eye Protection: Chemical safety goggles.

---

9 - Physical and Chemical Properties

---

Appearance Physical State: Solid
Property Value At Temperature or Pressure
pH N/A
BP/BP Range N/A
MP/MP Range N/A
Flash Point N/A
Flammability N/A
ALDRICH www.molbase.com
Autoignition Temp N/A
Oxidizing Properties N/A
Explosive Properties N/A
Explosion Limits N/A
Vapor Pressure N/A
Partition Coefficient N/A
Viscosity N/A
Vapor Density N/A
Saturated Vapor Conc. N/A
Evaporation Rate N/A
Bulk Density N/A
Decomposition Temp. N/A
Solvent Content N/A
Water Content N/A
Surface Tension N/A
Conductivity N/A
Miscellaneous Data N/A
Solubility N/A

---

10 - Stability and Reactivity

---

STABILITY
Stable: Stable.
Materials to Avoid: Strong oxidizing agents.
HAZARDOUS DECOMPOSITION PRODUCTS
Hazardous Decomposition Products: Carbon monoxide, Carbon dioxide,
Nitrogen oxides.
HAZARDOUS POLYMERIZATION
Hazardous Polymerization: Will not occur

---

11 - Toxicological Information

---

SIGNS AND SYMPTOMS OF EXPOSURE
To the best of our knowledge, the chemical, physical, and
toxicological properties have not been thoroughly investigated.
ROUTE OF EXPOSURE
Skin Contact: May cause skin irritation.
Skin Absorption: May be harmful if absorbed through the skin.
Eye Contact: May cause eye irritation.
Inhalation: Material may be irritating to mucous membranes and
upper respiratory tract. May be harmful if inhaled.
Ingestion: May be harmful if swallowed.

---

12 - Ecological Information

---

No data available.

---

13 - Disposal Considerations

---

SUBSTANCE DISPOSAL
Contact a licensed professional waste disposal service to dispose
of this material. Dissolve or mix the material with a combustible
solvent and burn in a chemical incinerator equipped with an
afterburner and scrubber. Observe all federal, state, and local
environmental regulations.

---

14 - Transport Information
ALDRICH www.molbase.com

---

RID/ADR
Non-hazardous for road transport.
IMDG
Non-hazardous for sea transport.
IATA
Non-hazardous for air transport.

---

15 - Regulatory Information

---

Not hazardous according to Directive 67/548/EEC.
Caution: Substance not yet fully tested (EU).

---

16 - Other Information

---

WARRANTY
The above information is believed to be correct but does not
purport to be all inclusive and shall be used only as a guide. The
information in this document is based on the present state of our
knowledge and is applicable to the product with regard to
appropriate safety precautions. It does not represent any
guarantee of the properties of the product. Inc.,
shall not be held liable for any damage resulting from handling or
from contact with the above product. See reverse side of invoice
or packing slip for additional terms and conditions of sale.
Copyright 2010 Co. License granted to make
unlimitedpaper copies for internal use only.
DISCLAIMER
For R&D use only. Not for drug, household or other uses.
ALDRICH www.molbase.com

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  丙酯 在 氢氧化钾 作用下， 生成 (2-methyl-indol-3-yl)-glyoxylic acid
  参考文献：
  名称：

  Angeli; Marchetti, Atti della Accademia Nazionale dei Lincei, Classe di Scienze Fisiche, Matematiche e Naturali, Rendiconti, 1907, vol. <5> 16 II, p. 793

  摘要：

  DOI：
• 作为产物：
  描述：

  2-甲基吲哚 以 四氢呋喃 为溶剂， 反应 0.5h， 生成 丙酯
  参考文献：
  名称：

  Rhodium-catalyzed enantioselective 1,2-addition of arylboronic acids to heteroaryl α-ketoesters for synthesis of heteroaromatic α-hydroxy esters

  摘要：

  第一例催化不对称1,2-加成芳基硼酸到杂芳类α-酮酯的反应已经被开发，用于高效和选择性合成四次碳含量的杂芳类α-羟基酯。在非常温和的条件下，该反应对多种α-酮酯表现良好，包括3-吲哚乙二酸酯、3-苯并呋喃乙二酸酯和3-苯并噻吩乙二酸酯，产物的收率中等到良好，且具有高的对映体过量（高达97%）。

  DOI：

  10.1039/c2ob26316e

文献信息

• Design, Synthesis, and Biological Evaluation of 3,4-Diarylmaleimides as Angiogenesis Inhibitors
  作者：Christian Peifer、Thomas Stoiber、Eberhard Unger、Frank Totzke、Christoph Schächtele、Dieter Marmé、Ruth Brenk、Gerhard Klebe、Dieter Schollmeyer、Gerd Dannhardt

  DOI：10.1021/jm0580297

  日期：2006.2.1

  The new analogue 2 of combretastatin A-4 was discovered to be an inhibitor of tubulin polymerization with an IC50 of 7.6 microM and reduced angiogenesis in the in vivo chick embryo model. Interestingly, in a series of 2,3-diarylmaleimides closely related to this lead, no other compound was found to be active in the tubulin polymerization assay. However, by screening in the in vivo chick embryo assay

  发现康美他汀A-4的新类似物2是微管蛋白聚合的抑制剂，在体内鸡胚模型中的IC50为7.6 microM，并减少了血管生成。有趣的是，在一系列与该铅紧密相关的2，3-二芳基马来酰亚胺中，在微管蛋白聚合测定中未发现其他化合物具有活性。然而，通过在体内进行筛选，将雏鸡胚胎测定法10鉴定为有效的血管生成抑制剂，表明了另一种靶标。确实，分子建模研究表明在模型激酶CDK2的ATP结合位点有一个合理的10结合模式。根据这些结果，在10种类似的12种蛋白激酶中筛选了10种类似物的抑制活性，发现10种对VEGF-R2的高亲和力表明IC50为2.5 nM。
• Rhodium-catalyzed enantioselective 1,2-addition of arylboronic acids to heteroaryl α-ketoesters for synthesis of heteroaromatic α-hydroxy esters
  作者：Hui Wang、Ting-Shun Zhu、Ming-Hua Xu

  DOI：10.1039/c2ob26316e

  日期：——

  The first example of catalytic asymmetric 1,2-addition of arylboronic acids to heteroaryl α-ketoesters has been developed for the highly efficient and enantioselective synthesis of quaternary carbon-containing heteroaromatic α-hydroxy esters. The reaction works well with a variety of α-ketoesters including 3-indoleglyoxylates, 3-benzofuranglyoxylates and 3-benzothiopheneglyoxylates under very mild conditions, affording the corresponding products in moderate to good yields with high enantiomeric excesses (up to 97%).

  第一例催化不对称1,2-加成芳基硼酸到杂芳类α-酮酯的反应已经被开发，用于高效和选择性合成四次碳含量的杂芳类α-羟基酯。在非常温和的条件下，该反应对多种α-酮酯表现良好，包括3-吲哚乙二酸酯、3-苯并呋喃乙二酸酯和3-苯并噻吩乙二酸酯，产物的收率中等到良好，且具有高的对映体过量（高达97%）。
• Unusual Reactivity of Aryl Aldehydes with Triethyl Phosphite and Zinc Bromide: A Facile Preparation of Epoxides, Benzisoxazoles, and α-Hydroxy Phosphonate Esters
  作者：Potharaju Raju、Ganesan Gobi Rajeshwaran、Meganathan Nandakumar、Arasambattu K. Mohanakrishnan

  DOI：10.1002/ejoc.201500332

  日期：2015.6

  A facile preparation of trans-epoxides was achieved by a (EtO)3P–ZnBr2-mediated deoxygenation reaction of the corresponding 2-nitrobenzaldehydes. The sterically hindered analogues of 2-nitrobenzaldehyde underwent a reaction with triethyl phosphite in the presence of ZnBr2 as the catalyst to form benzisoxazoles as the sole product. Under identical conditions, the reactions of electron-rich as well as

  通过相应的 2-硝基苯甲醛的 (EtO)3P-ZnBr2 介导的脱氧反应，可以轻松制备反式环氧化物。2-硝基苯甲醛的空间位阻类似物在作为催化剂的 ZnBr2 存在下与亚磷酸三乙酯发生反应，形成苯并异恶唑作为唯一产物。在相同条件下，富电子和适度缺电子芳醛的反应提供相应的α-羟基膦酸酯。
• Pyrazolo[3,4-c]Quinolines, Pyrazolo[3,4-c]Naphthyridines, Analogs Thereof, and Methods
  申请人：Merrill Bryon A.

  公开号：US20090069299A1

  公开（公告）日：2009-03-12

  Pyrazolo[3,4-c]quinolines, pyrazolo[4,5-c]naphthyridines, and analogs thereof, eg., 6,7,8,9-tetrahydro pyrazolo[3,4-c]quinolines, and, pharmaceutical compositions containing the compounds, intermediates, methods of making these compounds, and methods of use of these compounds as immunomodulators, for inhibiting cytokine biosynthesis in animals and in the therapeutic or prophylactic treatment of diseases by inhibiting cytokine biosynthesis are disclosed.

  本发明涉及吡唑并[3,4-c]喹啉、吡唑并[4,5-c]萘啉及其类似物，例如6,7,8,9-四氢吡唑并[3,4-c]喹啉，以及含有这些化合物的制药组合物、中间体、制备这些化合物的方法以及将这些化合物用作免疫调节剂的方法，用于抑制动物体内的细胞因子生物合成，并在治疗或预防通过抑制细胞因子生物合成引起的疾病中使用。
• 1-substituted pyrazolo (3,4-C) ring compounds as modulators of cytokine biosynthesis for the treatment of viral infections and neoplastic diseases
  申请人：3M Innovative Properties Company

  公开号：US07943636B2

  公开（公告）日：2011-05-17

  Pyrazolo[3,4-c] ring compounds of Formula (I), e.g., pyrazolo[3,4-c]pyridines, pyrazolo[3,4-c]quinolines, 6,7,8,9-tetrahydro pyrazolo[3,4-c]quinolines, and pyrazolo[3,4-c]naphthyridines, substituted at the 1-position, pharmaceutical compositions containing the compounds, intermediates, methods of making and methods of use of these compounds as immunomodulators, for inducing cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases are disclosed.

  公开了式（I）的吡唑并[3,4-c]环化合物，例如吡唑并[3,4-c]吡啶、吡唑并[3,4-c]喹啉、6,7,8,9-四氢吡唑并[3,4-c]喹啉和吡唑并[3,4-c]萘啉，它们在1位被取代，以及含有这些化合物的制药组合物、中间体、制备方法和用于作为免疫调节剂、诱导动物细胞因子生物合成以及治疗包括病毒和肿瘤疾病的方法。

表征谱图